Literature DB >> 25840900

Computing Expected Value of Partial Sample Information from Probabilistic Sensitivity Analysis Using Linear Regression Metamodeling.

Hawre Jalal1,2, Jeremy D Goldhaber-Fiebert2, Karen M Kuntz3.   

Abstract

Decision makers often desire both guidance on the most cost-effective interventions given current knowledge and also the value of collecting additional information to improve the decisions made (i.e., from value of information [VOI] analysis). Unfortunately, VOI analysis remains underused due to the conceptual, mathematical, and computational challenges of implementing Bayesian decision-theoretic approaches in models of sufficient complexity for real-world decision making. In this study, we propose a novel practical approach for conducting VOI analysis using a combination of probabilistic sensitivity analysis, linear regression metamodeling, and unit normal loss integral function--a parametric approach to VOI analysis. We adopt a linear approximation and leverage a fundamental assumption of VOI analysis, which requires that all sources of prior uncertainties be accurately specified. We provide examples of the approach and show that the assumptions we make do not induce substantial bias but greatly reduce the computational time needed to perform VOI analysis. Our approach avoids the need to analytically solve or approximate joint Bayesian updating, requires only one set of probabilistic sensitivity analysis simulations, and can be applied in models with correlated input parameters.
© The Author(s) 2015.

Entities:  

Keywords:  Bayesian statistical methods; cost-benefit analysis; probabilistic sensitivity analysis; simulation methods; value of information

Mesh:

Year:  2015        PMID: 25840900      PMCID: PMC4978941          DOI: 10.1177/0272989X15578125

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  45 in total

1.  Fieller's method and net health benefits.

Authors:  D F Heitjan
Journal:  Health Econ       Date:  2000-06       Impact factor: 3.046

2.  Efficient computation of partial expected value of sample information using Bayesian approximation.

Authors:  Alan Brennan; Samer A Kharroubi
Journal:  J Health Econ       Date:  2006-08-30       Impact factor: 3.883

3.  The value of information and optimal clinical trial design.

Authors:  Andrew R Willan; Eleanor M Pinto
Journal:  Stat Med       Date:  2005-06-30       Impact factor: 2.373

4.  A rational framework for decision making by the National Institute For Clinical Excellence (NICE).

Authors:  Karl Claxton; Mark Sculpher; Michael Drummond
Journal:  Lancet       Date:  2002-08-31       Impact factor: 79.321

5.  Value of information and pricing new healthcare interventions.

Authors:  Andrew R Willan; Simon Eckermann
Journal:  Pharmacoeconomics       Date:  2012-06-01       Impact factor: 4.981

6.  Accounting for between-study variation in incremental net benefit in value of information methodology.

Authors:  Andrew R Willan; Simon Eckermann
Journal:  Health Econ       Date:  2011-09-01       Impact factor: 3.046

Review 7.  Why sources of heterogeneity in meta-analysis should be investigated.

Authors:  S G Thompson
Journal:  BMJ       Date:  1994-11-19

8.  Value of information and value of implementation: application of an analytic framework to inform resource allocation decisions in metastatic hormone-refractory prostate cancer.

Authors:  Ties Hoomans; Elisabeth A L Fenwick; Steve Palmer; Karl Claxton
Journal:  Value Health       Date:  2008-07-24       Impact factor: 5.725

9.  Expected value of sample information calculations in medical decision modeling.

Authors:  A E Ades; G Lu; K Claxton
Journal:  Med Decis Making       Date:  2004 Mar-Apr       Impact factor: 2.583

10.  An iterative Bayesian approach to health technology assessment: application to a policy of preoperative optimization for patients undergoing major elective surgery.

Authors:  Elisabeth Fenwick; Steve Palmer; Karl Claxton; Mark Sculpher; Keith Abrams; Alex Sutton
Journal:  Med Decis Making       Date:  2006 Sep-Oct       Impact factor: 2.583

View more
  17 in total

1.  Prioritizing Future Research on Allopurinol and Febuxostat for the Management of Gout: Value of Information Analysis.

Authors:  Eric Jutkowitz; Fernando Alarid-Escudero; Hyon K Choi; Karen M Kuntz; Hawre Jalal
Journal:  Pharmacoeconomics       Date:  2017-10       Impact factor: 4.981

2.  The Curve of Optimal Sample Size (COSS): A Graphical Representation of the Optimal Sample Size from a Value of Information Analysis.

Authors:  Eric Jutkowitz; Fernando Alarid-Escudero; Karen M Kuntz; Hawre Jalal
Journal:  Pharmacoeconomics       Date:  2019-07       Impact factor: 4.981

3.  Prioritizing Additional Data Collection to Reduce Decision Uncertainty in the HIV/AIDS Response in 6 US Cities: A Value of Information Analysis.

Authors:  Xiao Zang; Hawre Jalal; Emanuel Krebs; Ankur Pandya; Haoxuan Zhou; Benjamin Enns; Bohdan Nosyk
Journal:  Value Health       Date:  2020-10-03       Impact factor: 5.725

4.  Metamodeling for Policy Simulations with Multivariate Outcomes.

Authors:  Huaiyang Zhong; Margaret L Brandeau; Golnaz Eftekhari Yazdi; Jianing Wang; Shayla Nolen; Liesl Hagan; William W Thompson; Sabrina A Assoumou; Benjamin P Linas; Joshua A Salomon
Journal:  Med Decis Making       Date:  2022-06-23       Impact factor: 2.749

5.  Personalization of Medical Treatment Decisions: Simplifying Complex Models while Maintaining Patient Health Outcomes.

Authors:  Christopher Weyant; Margaret L Brandeau
Journal:  Med Decis Making       Date:  2021-08-20       Impact factor: 2.749

6.  Calculating the Expected Value of Sample Information in Practice: Considerations from 3 Case Studies.

Authors:  Anna Heath; Natalia Kunst; Christopher Jackson; Mark Strong; Fernando Alarid-Escudero; Jeremy D Goldhaber-Fiebert; Gianluca Baio; Nicolas A Menzies; Hawre Jalal
Journal:  Med Decis Making       Date:  2020-04-16       Impact factor: 2.583

7.  Implementing Generalized Additive Models to Estimate the Expected Value of Sample Information in a Microsimulation Model: Results of Three Case Studies.

Authors:  Dustin J Rabideau; Pamela P Pei; Rochelle P Walensky; Amy Zheng; Robert A Parker
Journal:  Med Decis Making       Date:  2017-11-09       Impact factor: 2.583

8.  Cost-effectiveness of teduglutide in adult patients with short bowel syndrome: Markov modeling using traditional cost-effectiveness criteria.

Authors:  Vikram K Raghu; David G Binion; Kenneth J Smith
Journal:  Am J Clin Nutr       Date:  2020-01-01       Impact factor: 7.045

9.  Is further research on adult pneumococcal vaccine uptake improvement programs worthwhile? Α value of information analysis.

Authors:  Angela R Wateska; Mary Patricia Nowalk; Hawre Jalal; Chyongchiou J Lin; Lee H Harrison; William Schaffner; Richard K Zimmerman; Kenneth J Smith
Journal:  Vaccine       Date:  2021-05-25       Impact factor: 4.169

10.  Computing the Expected Value of Sample Information Efficiently: Practical Guidance and Recommendations for Four Model-Based Methods.

Authors:  Natalia Kunst; Edward C F Wilson; David Glynn; Fernando Alarid-Escudero; Gianluca Baio; Alan Brennan; Michael Fairley; Jeremy D Goldhaber-Fiebert; Chris Jackson; Hawre Jalal; Nicolas A Menzies; Mark Strong; Howard Thom; Anna Heath
Journal:  Value Health       Date:  2020-05-27       Impact factor: 5.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.